CFDE Data Portal | Search MTCO3P13

	Label	Description
	MTCO3P13 Gene (Entity type)	ENSG00000264316 - MT-CO3 pseudogene 13
	GSE222758 clofazimine U2OS 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE149359 ASAP2 knockout MIA PaCa-2 PANC-1 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	FZD10 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	TAS2R10 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE178292 melphalan 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

MTCO3P13

ENSG00000264316 - MT-CO3 pseudogene 13

GSE222758 clofazimine U2OS 0 v 2 human dn

A Gene Set from LINCS

GSE149359 ASAP2 knockout MIA PaCa-2 PANC-1 3 v 0 human dn

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 3 v 0 human up

A Gene Set from LINCS

GSE135514 dasatinib 2 v 7 human dn

A Gene Set from LINCS

FZD10 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

TAS2R10 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GSE178292 melphalan 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.